Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices-Reference-Cited by-同舟云学术

Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices

Published:2020-11-03 Issue: Volume:8 Page:
ISSN:2296-4185
Container-title:Frontiers in Bioengineering and Biotechnology
language:
Short-container-title:Front. Bioeng. Biotechnol.

Author:

Jemni-Damer Nahla,Guedan-Duran Atocha,Fuentes-Andion María,Serrano-Bengoechea Nora,Alfageme-Lopez Nuria,Armada-Maresca Felix,Guinea Gustavo V.,Pérez-Rigueiro José,Rojo Francisco,Gonzalez-Nieto Daniel,Kaplan David L.,Panetsos Fivos

Publisher

Frontiers Media SA

Subject

Biomedical Engineering,Histology,Bioengineering,Biotechnology

Reference226 articles.

1. Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration.;Abrishami;Retina,2009

2. The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 inhibitor specifically designed for topical ocular delivery, as a therapy for neovascular age-.;Adams;J. Med. Chem.,2018

3. In situ gel systems as “smart” carriers for sustained ocular drug delivery.;Agrawal;Expert Opin. Drug Deliv.,2012

4. Polyethylene glycol (PEG)–Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications.;Alexander;Eur. J. Pharm. Biopharm.,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of using Traditional Chinese Medicine in the management of glaucoma and cataract;Clinical and Experimental Optometry;2023-10-25

2. Application of organic nanocarriers for intraocular drug delivery;Journal of Zhejiang University (Medical Sciences);2023-06-01

3. Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution;Pharmaceutics;2022-08-31

4. Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective;Pharmaceutics;2022-05-03

5. Human Stem Cell Transplantation for Retinal Degenerative Diseases: Where Are We Now?;Medicina;2022-01-10